FELIQS

Our CEO, Ken-ichiro "Nobu" Kuninobu, Ph.D., was invited to present at the Ministry of Economy, Trade and Industry event in Kyushu. We are honored to be there and believe our track record is unique and attractive for global partners. We would like to support the acceleration of making a biotech ecosystem in Japan, led by the Ministry of Economy, Trade and Industry.

FELIQS has been again selected as the Winning Pitch Challenge finalist in Eyecelerator 2024 on October 17th! Our CEO, Ken-Ichiro "Nobu" Kuninobu, Ph.D, will give a short video presentation at the Honorable Mention. This is the second time in a row that FELIQS has been selected to present in the Winning Pitch Challenge. Eyecelerator is one of the largest start-up conferences in the ophthalmology arena, and it is truly honored to update our progress to investors and strategics. On behalf of FELIQS, ken-ichiro "Nobu" K. and MaryJane R. will attend AAO 2024 in Chicago. Happy to connect with you!

【Japanese-only article】日本経済新聞社, the leading business newspaper in Japan, featured FELIQS in their latest article about biotech start-ups in Japan. Our CEO, ken-ichiro "Nobu" K. was interviewed since we are the only Japanese start-up company selected in the Start-Up Stadium. Our series A fundraising activity was significantly boosted by the participation in #BIO2024. https://lnkd.in/dnkFyY5w

Exciting #BIO2024 is ongoing! Our CEO, ken-ichiro "Nobu" K., presented at Startup Stadium for 2 years in a row. The judges understood our approach well and we have shown robust progress since the Start-up Stadium in 2023. With the successful presence in #BIO2024, we are heading to raise a $25M Series A round.

Team FELIQS, ken-ichiro "Nobu" K., MaryJane R., is excited to attend BIO2024 in San Diego next week. Thanks to the increase in the attractiveness of retinal diseases, we will meet many strategics and investors. In addition, our CEO, ken-ichiro "Nobu" K., will present our strong progress in pipelines in the retinal space and this is a great opportunity to understand us. Please secure your slot to watch our presentation from 12:30 PM - 12:50 PM on Tuesday, June 04, 2024 at the Upper Level, Room 5B. We are looking forward to meeting you at BIO2024.

The latest publication came from Dr.Kenichi Yamada, co-founder and CSO of FELIQS and distinguished professor of Kyushu University. This is one of the core technologies that FELIQS utilizes for drug discovery and clinical applications. This technology is beneficial to enhance oxidized lipids drug discovery science. Please read this article to see why we are so good at drug discovery and bring the assets to the clinic efficiently. https://lnkd.in/dQEtQzWE

FELIQS has been selected as a finalist of Start-Up Stadium at BIO 2024!! This is 2 years in a row of success and we are the only Japanese entity to present. Our CEO, ken-ichiro "Nobu" K., will present our strong progress since last year. Please secure your slot for our presentation at 12:30 PM - 1:00 PM on Tuesday, June 04, 2024, and we are happy to meet you at BIO2024. https://lnkd.in/geqMJfXr

Our CEO, ken-ichiro "Nobu" K., joined and enjoyed the ARVO2024. We have communicated with many industry and academic experts who are fighting for brightness. One interesting move is the first-time participation of Boehringer Ingelheim in the retinal field. Their phase 1 program is a phospholipid modulator targeting oxidized lipids which is something the same as ours. We felt much more attracted to the space we are working on and will try to initiate clinical trials as soon as possible.

FELIQS's memorial debut in OIS. Our CEO, ken-ichiro "Nobu" K., made a great presentation in Spotlight On Dry AMD & GA and attracted big attention to ferroptosis in the ophthalmology community with the nice introduction by Dr.Andrew Moshfeghi. We continue to move forward to provide differentiated care to the patients. Thank you for OIS for having this excellent opportunity.

FELIQS has been selected as one of the Winning Pitch Challenge finalists in Eyecelerator ASCRS 2024 on April 3rd. Our CEO, ken-ichiro "Nobu" K., will make a short video presentation in the Honorable Mention. On behalf of FELIQS, MaryJane R., will attend ASCRS 2024 in Boston. Enjoy the meeting!